Clinical measures of disease staging in FTD have only recently been designed (such as the Frontotemporal Lobar Degeneration-Clinical Dementia Rating34 and Frontotemporal Dementia Rating Scale35) and were not available in this cohort; it will be important for future studies to compare such measures with serum NfL levels. Here, NEFL is linked to frontotemporal dementia.